Ignite Creation Date:
2024-05-06 @ 3:24 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04620590
Status:
UNKNOWN
Last Update Posted:
2021-09-08
First Post:
2020-11-03
Brief Title:
An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function
Sponsor:
George Clinical Pty Ltd
Organization:
George Clinical Pty Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Impaired Renal Function |
| Diabetes Mellitus Type 2 |
Keywords: